vitexin-2-O-rhamnoside,
Vitexin-2''-rhamnoside,
64820-99-1,
Vitexin-2-O-rhamnoside,
Vitexin 2''-rhamnoside,
UNII-UD7Y63I5X5,
2-O-Rhamnosylvitexin,
Apigenin-8-C-glucoside-2'-rhamnoside,
Vitexin 2''-O-rhamnoside,
Vitexin-2''-O-rhamnoside,
2''-O-Rhamnosylvitexin,
UD7Y63I5X5,
CHEBI:32298,
vitexin 2''-O-alpha-L-rhamnoside,
(1S)-1,5-anhydro-2-O-(6-deoxy-alpha-L-mannopyranosyl)-1-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-8-yl]-D-glucitol,
(1S)-1,5-anhydro-2-O-(alpha-L-rhamnopyranosyl)-1-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-8-yl]-D-glucitol,
8-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one,
Vitexin 2-O-rhamnoside,
AC1NQZK5,
Vitexin 2"-O-rhamnoside,
MEGxp0_001018,
SCHEMBL1954688,
CHEMBL1685070,
ACon1_001257,
DTXSID20215119,
EBD42622,
KS-00000H9G,
ZINC4654801,
AKOS015897136,
MCULE-4369219700,
NCGC00169526-01,
AN-10376,
Vitexin 2-O-rhamnoside, analytical standard,
C12628,
I07-0297,
BRD-K00786504-001-01-8,
Vitexin 2-O-rhamnoside, primary pharmaceutical reference standard,
4H-1-Benzopyran-4-one,8-[2-O-(6-deoxy-a-L-mannopyranosyl)-b-D-glucopyranosyl]-5,7-dihydroxy-2-(4-hydroxyphenyl)-,
8-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one,
Vitexin rhamnoside,
Apigenin-8-C-glucoside,
Vitexin 2''-O-beta-L-rhamnoside,
CS-BS-00310,
ACN-035537,
CID5282151,
C27-H30-O14,